🔔Stock Alerts via Telegram — Free for All Users

VSEE Stock Risk & Deep Value Analysis

Vsee Health Inc

Healthcare • Health Information Services

DVR Score

1.0

out of 10

Distressed

What You Need to Know About VSEE Stock

We analyzed Vsee Health Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran VSEE through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.

Updated Mar 24, 2026Run Fresh Analysis →

VSEE Risk Analysis & Red Flags

Risk Matrix

Overall

Aggressive

Financial

High

Market

High

Competitive

High

Execution

High

Regulatory

Medium

Upcoming Risk Events

  • 📅

    Continued negative operating cash flow leading to further dilution or bankruptcy risk

  • 📅

    Failure to secure additional financing to support operations

  • 📅

    Increased competition in the telehealth market without a clear moat

  • 📅

    Potential delisting due to low stock price or failure to meet exchange requirements

Unlock VSEE Risk Analysis & Red Flags

Create a free account to see the full analysis

What Does Vsee Health Inc (VSEE) Do?

Market Cap

$11.76M

Sector

Healthcare

Industry

Health Information Services

Employees

154

VSee Health, Inc. provides telehealth care solutions in the United States. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. It also provides telehealth software building blocks, such as patient engagement, clinician staffing, remote physical exam and remote patient monitoring, and AI for telesitter and telenursing solutions; data connectors; and workflow templates. The company distributes its products through third-party resellers and affiliated hospitals, as well as sales executives. VSee Health, Inc. is headquartered in Newton, Massachusetts.

Visit Vsee Health Inc Website

Investment Thesis

Investment in VSEE represents an extremely high-risk, pure speculation play with minimal fundamental support. The bull case relies entirely on an unforeseen, transformative event (e.g., a major strategic partnership, a successful radical pivot, or an unexpected acquisition) that could capitalize on its micro-cap status to generate substantial percentage returns from its current low base. This scenario is highly improbable given current data.

Is VSEE Stock Undervalued?

Vsee Health Inc (VSEE) remains an extremely high-risk, highly speculative micro-cap. There have been no material announcements, positive financial shifts, or strategic developments since the last analysis 49 days ago (2026-02-03) that would alter its precarious outlook. The company continues to exhibit severe financial distress with negative net income (-$57.7M TTM), negative operating cash flow (-$5.79M TTM), and negative book value per share (-$0.33). Transparency is low, with no recent SEC filings or earnings reports available. While a single analyst projects significant upside, this is an outlier and unsupported by current fundamentals. Without a clear competitive advantage, a viable path to profitability, or significant catalysts, the 10x growth potential within 3-5 years is virtually non-existent, and the risk of capital loss remains exceptionally high. The score remains consistent with previous assessments due to the unchanged challenging conditions.

Unlock the full AI analysis for VSEE

Get the complete DVR score, risk analysis, and more

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

VSEE Price Targets & Strategy

12-Month Target

$0.36

Bull Case

$5.00

Bear Case

$0.05

Valuation Basis

1.5x TTM P/S applied to $10.42M revenue (speculative multiple for potential stabilization)

Entry Strategy

Extremely cautious dollar-cost averaging only after significant positive fundamental news (e.g., successful capital raise, major partnership), with an entry limit below current price (e.g., $0.20-$0.25) given high risk and lack of clear support levels.

Exit Strategy

Take profit on any significant rallies (e.g., >50% from entry) as they are likely speculative. Implement a strict stop-loss order (e.g., $0.15) to limit potential losses given the company's precarious financial position.

Portfolio Allocation

Less than 0.5% for highly aggressive, speculative portfolios only. Not recommended for conservative or moderate investors.

Price Targets & Strategy

Upgrade to Premium for price targets and entry/exit strategies

Is VSEE Financially Healthy?

Profitability

Operating Margin

-52.00%

Net Margin

-70.00%

Return on Equity

-2.60%

Balance Sheet

Cash & Equivalents

$321,800

Cash Flow

Operating Cash Flow

-$5.00M

Does VSEE Have a Competitive Moat?

Sign in to unlock

Moat Rating

⚪ None

Moat Trend

Eroding

The company shows no evidence of durable competitive advantages. Its financial distress, lack of transparency, and absence of a clear market strategy make any potential moat highly fragile and susceptible to competitive pressures.

Moat Erosion Risks

  • Intense competition in the telehealth sector
  • Inability to secure sufficient capital for innovation and growth
  • Lack of proprietary technology or strong brand recognition
  • Reliance on undifferentiated services

VSEE Competitive Moat Analysis

Sign up to see competitive advantages

VSEE Market Intelligence

Sentiment & Insider Activity

Social Sentiment

Neutral/Unknown (no specific data available in research brief)

Institutional Sentiment

Mixed. One analyst rates Buy with a median price target of $5.00 (highly bullish outlier); institutional ownership is 11.81% but no recent buying trends are specified.

Insider Activity (Form 4)

No specific Form 4 filings reported in the last 90 days. Insider ownership stands at 17.23%.

Options Flow

Normal options activity (no specific unusual activity reported)

Earnings Intelligence

Next Earnings

No expected date or consensus estimates available

Surprise Probability

Low (due to lack of estimates and severe unprofitability)

Historical Earnings Pattern

No historical earnings data or reaction patterns available.

Key Metrics to Watch

Revenue stabilization and growthReduction in net losses and improved operating marginsPositive operating cash flow trajectoryUpdates on total cash position and debt management

Competitive Position

Top Competitor

Not identified in research brief for VSEE, generally competes with broader telehealth platforms (e.g., Teladoc, Amwell)

Market Share Trend

Unknown, likely negligible or losing due to lack of competitive advantage and financial struggles.

Valuation vs Peers

Trading at P/S of ~1.02x, which is comparable or slightly higher than some more established telehealth peers (e.g., TDOC ~0.7x, AMWL ~0.6x) despite significantly worse profitability, suggesting it may be overvalued on a fundamental basis given its current state.

Competitive Advantages

  • None identified in research brief. Company lacks clear differentiators in a crowded market.

Market Intelligence

Get sentiment, earnings intel, and peer analysis with Premium

What Could Drive VSEE Stock Higher?

Near-Term (0-6 months)

  • No expected earnings date or estimates available (High uncertainty)
  • No specific product launches or strategic announcements identified in research brief

Medium-Term (6-18 months)

  • Potential (unspecified) strategic partnerships or capital raise efforts
  • Improved clarity on business model and market share strategy

Long-Term (18+ months)

  • Successful pivot or acquisition leading to integration into a larger platform
  • Unforeseen industry disruption if VSEE somehow develops a unique, scalable solution

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

What's the Bull Case for VSEE?

  • Official SEC filings (10-K/10-Q) with clear financial and operational updates

  • Announcements of significant strategic partnerships or customer wins

  • Evidence of positive operating cash flow and a clear path to profitability

  • Any C-suite leadership changes with proven industry expertise

Bull Case Analysis

See what could go right with Premium

Competing with VSEE

See how Vsee Health Inc compares to related companies

CompanyMarket CapDVR ScoreP/ERevenueProfit MarginRev Growth

Vsee Health Inc

VSEE

$11.8M1.0-70.0%0.0%

AbbVie Inc

ABBV

$403.8B0.1171.8Compare →

Johnson & Johnson

JNJ

1.0Compare →

Eli Lilly and Co

LLY

$965.0B0.552.6Compare →

Pfizer Inc

PFE

$150.6B0.219.4$62.6B12.4%-1.6%Compare →

UnitedHealth Group Inc

UNH

$276.2B0.322.9$113.7B2.7%1181.0%Compare →

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

FAQ

What is the DVR Score for Vsee Health Inc (VSEE)?

As of March 24, 2026, Vsee Health Inc has a DVR Score of 1.0 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Vsee Health Inc?

Vsee Health Inc's market capitalization is approximately $11.8M. The company operates in the Healthcare sector within the Health Information Services industry.

What ticker symbol does Vsee Health Inc use?

VSEE is the ticker symbol for Vsee Health Inc. The company trades on the NCM.

What is the risk level for VSEE stock?

Our analysis rates Vsee Health Inc's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

Is Vsee Health Inc's revenue growing?

Vsee Health Inc has reported revenue growth of 0.0%. Revenue has been declining, which warrants closer examination.

Is VSEE stock profitable?

Vsee Health Inc has a profit margin of -70.0%. The company is currently unprofitable.

How often is the VSEE DVR analysis updated?

Our AI-powered analysis of Vsee Health Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 24, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for VSEE (Vsee Health Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

Navigated to VSEE Stock Risk & Deep Value Analysis